INDGN
1 call
Concalls & earnings callsIndegene Limited
Every summarised call, newest first. Latest is Q1 FY27, held 13 Aug 2026.
Latest quarter
Q1 FY27 snapshot
Open full brief →The company is positioned as a strategic operating partner for the global life sciences industry, focusing on embedding AI to transform client operations and drive growth, while aiming to recover margins after a year of heavy investment.
| Metric | This quarter | Change | Five-quarter trend |
|---|---|---|---|
| Revenue | ₹3,510.5 Cr | 23.6% | |
| EBITDA | ₹624.7 Cr | 11.1% | |
| Profit After Tax | ₹401.1 Cr | — | |
| Operating Cash Flow | ₹650 Cr | — |
Latest guidance
- EBITDA margins expected to return to the 19% to 20% band by Q4 FY27.
- Growth investments (150 bps impact) to normalize by end of FY27.
- Amortization charge to decline by about INR 50 crores every quarter starting Q3.
- Capex for FY27 expected to be around 1% of revenue.
- Dividend policy: to consider increases based on strong cash flow generation.
Said on the Q1 FY27 call.
Filed results
Reported quarterly history
From filed quarterly results. YoY and QoQ compare each metric on the same accounting basis.
| Quarter | Revenue | Net profit (PAT) | Basic EPS |
|---|---|---|---|
| Q3 FY25 | ₹720.40 Cr— YoY+4.9% QoQ | ₹109.70 Cr— YoY+19.6% QoQ | ₹4.59— YoY+19.5% QoQ |
| Q2 FY25 | ₹686.80 Cr— YoY+1.5% QoQ | ₹91.70 Cr— YoY+4.6% QoQ | ₹3.84— YoY+1.3% QoQ |
| Q1 FY25 | ₹676.50 Cr— YoY+0.5% QoQ | ₹87.70 Cr— YoY-7.5% QoQ | ₹3.79— YoY-11.2% QoQ |
| Q4 FY24 | ₹673.00 Cr— YoY— QoQ | ₹94.80 Cr— YoY— QoQ | ₹4.27— YoY— QoQ |
Call history
- Q1 FY27Positive tone
The company is positioned as a strategic operating partner for the global life sciences industry, focusing on embedding AI to transform client operations and drive growth, while aiming to recover margins after a year of heavy investment.
- Revenue
- ₹3,510.5 Cr23.6%
- EBITDA
- ₹624.7 Cr11.1%